Indications
Neuropathic pain Lyrica is indicated for the treatment of peripheral and central neuropathic pain in adults. Epilepsy Lyrica is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation. Generalised anxiety disorder Lyrica is indicated for the treatment of generalised anxiety disorder (GAD) in adults.
Composition
- Active substance
- pregabalin
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Lyrica
- Active substance
- pregabalin
- ATC code
- N02BF02
- Group
- Nervous system
- Therapeutic area
- Epilepsy, Anxiety Disorders, Neuralgia
- Marketing authorisation holder
- Upjohn EESV